Earlier studies on the crosstalk between CAFs and DCs in different cancer models suggest that CAF-mediated immunoregulation on DCs is achieved via release of the cytokine thymic stromal lymphopoietin (TSLP) or expression of the catalytic enzyme tryptophan 2,3 dioxygenase (TDO2). Here, TSLP is linked to cancer.